Onderneming Intercept Pharmaceuticals, Inc.
Aandelen
ICPT
US45845P1084
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 341
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23-02-17 |
Andrew Saik
DFI | Director of Finance/CFO | 54 | 21-06-21 |
M. Berrey
CTO | Chief Tech/Sci/R&D Officer | 57 | 09-06-21 |
Jose Truzman
SEC | Corporate Secretary | - | - |
Rocco Venezia
AUD | Comptroller/Controller/Auditor | 48 | 01-01-16 |
General Counsel | 55 | 11-01-21 | |
Corporate Officer/Principal | 60 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23-02-17 |
Director/Board Member | 55 | 08/11 | |
Stefano Pasi
BRD | Director/Board Member | - | 08/11 |
Michele Cera
BRD | Director/Board Member | - | 08/11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 41 825 966 | 40 940 614 ( 97,88 %) | 0 | 97,88 % |
Bedrijfsgegevens
Intercept Pharmaceuticals, Inc.
305 Madison Avenue
07960, Morristown
+646 747 1000
http://www.interceptpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |